221 research outputs found
DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells
Facioscapulohumeral muscular dystrophy (FSHD) is linked to the deletion of the D4Z4 arrays at chromosome 4q35. Recent studies suggested that aberrant expression of double homeobox 4 (DUX4) from the last D4Z4 repeat causes FSHD. The aim of this study is to determine transcriptomic responses to ectopically expressed DUX4 in human and mouse cells of muscle lineage. We expression profiled human rhabdomyosarcoma (RD) cells and mouse C2C12 cells transfected with expression vectors of DUX4 using the Affymetrix Human Genome U133 Plus 2.0 Arrays and Mouse Genome 430 2.0 Arrays, respectively. A total of 2267 and 150 transcripts were identified to be differentially expressed in the RD and C2C12 cells, respectively. Amongst the transcripts differentially expressed in the RD cells, MYOD and MYOG (2 fold, p\u3c0.05), and six MYOD downstream targets were up-regulated in RD but not C2C12 cells. Furthermore, 13 transcripts involved in germline function were dramatically induced only in the RD cells expressing DUX4. The top 3 IPA canonical pathways affected by DUX4 were different between the RD (inflammation, BMP signaling and NRF-2 mediated oxidative stress) and the C2C12 cells (p53 signaling, cell cycle regulation and cellular energy metabolism). Amongst the 40 transcripts shared by the RD and C2C12 cells, UTS2 was significantly induced by 76 fold and 224 fold in the RD and C2C12 cells, respectively. The differential expression of MYOD, MYOG and UTS2 were validated using real-time quantitative RT-PCR. We further validated the differentially expressed genes in immortalized FSHD myoblasts and showed up-regulation of MYOD, MYOG, ZSCAN4 and UTS2. The results suggest that DUX4 regulates overlapped and distinct groups of genes and pathways in human and mouse cells as evident by the selective up-regulation of genes involved in myogenesis and gametogenesis in human RD and immortalized cells as well as the different molecular pathways identified in the cells
miR-411 is up-regulated in FSHD myoblasts and suppresses myogenic factors
Background
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant muscle disorder, which is linked to the contraction of the D4Z4 array at chromosome 4q35. Recent studies suggest that this shortening of the D4Z4 array leads to aberrant expression of double homeobox protein 4 (DUX4) and causes FSHD. In addition, misregulation of microRNAs (miRNAs) has been reported in muscular dystrophies including FSHD. In this study, we identified a miRNA that is differentially expressed in FSHD myoblasts and investigated its function. Methods
To identify misregulated miRNAs and their potential targets in FSHD myoblasts, we performed expression profiling of both miRNA and mRNA using TaqMan Human MicroRNA Arrays and Affymetrix Human Genome U133A plus 2.0 microarrays, respectively. In addition, we over-expressed miR-411 in C2C12 cells to determine the effect of miR-411 on myogenic markers. Results
Using miRNA and mRNA expression profiling, we identified 8 miRNAs and 1,502 transcripts that were differentially expressed in FSHD myoblasts during cell proliferation. One of the 8 differentially expressed miRNAs, miR-411, was validated by quantitative RT-PCR in both primary (2.1 fold, p\u3c0.01) and immortalized (2.7 fold, p\u3c0.01) myoblasts. In situ hybridization showed cytoplasmic localization of miR-411 in FSHD myoblasts. By analyzing both miRNA and mRNA data using Partek Genomics Suite, we identified 4 mRNAs potentially regulated by miR-411 including YY1 associated factor 2 (YAF2). The down-regulation of YAF2 in immortalized myoblasts was validated by immunoblotting (â3.7 fold, p\u3c0.01). C2C12 cells were transfected with miR-411 to determine whether miR-411 affects YAF2 expression in myoblasts. The results showed that over-expression of miR-411 reduced YAF2 mRNA expression. In addition, expression of myogenic markers including Myod, myogenin, and myosin heavy chain 1 (Myh1) were suppressed by miR-411. Conclusions
The study demonstrated that miR-411 was differentially expressed in FSHD myoblasts and may play a role in regulating myogenesis
Molecular signatures of differential responses to exercise trainings during rehabilitation.
The loss and recovery of muscle mass and function following injury and during rehabilitation varies among individuals. While recent expression profiling studies have illustrated transcriptomic responses to muscle disuse and remodeling, how these changes contribute to the physiological responses are not clear. In this study, we quantified the effects of immobilization and subsequent rehabilitation training on muscle size and identified molecular pathways associated with muscle responsiveness in an orthopaedic patient cohort study. The injured leg of 16 individuals with ankle injury was immobilized for a minimum of 4 weeks, followed by a 6-week rehabilitation program. The maximal cross-sectional area (CSA) of the medial gastrocnemius muscle of the immobilized and control legs were determined by T1-weighted axial MRI images. Genome-wide mRNA profiling data were used to identify molecular signatures that distinguish the patients who responded to immobilization and rehabilitation and those who were considered minimal responders. RESULTS: Using 6% change as the threshold to define responsiveness, a greater degree of changes in muscle size was noted in high responders (â14.9 ± 3.6%) compared to low responders (0.1 ± 0.0%) during immobilization. In addition, a greater degree of changes in muscle size was observed in high responders (20.5 ± 3.2%) compared to low responders (2.5 ± 0.9%) at 6-week rehabilitation. Microarray analysis showed a higher number of genes differentially expressed in the responders compared to low responders in general; with more expression changes observed at the acute stage of rehabilitation in both groups. Pathways analysis revealed top molecular pathways differentially affected in the groups, including genes involved in mitochondrial function, protein turn over, integrin signaling and inflammation. This study confirmed the extent of muscle atrophy due to immobilization and recovery by exercise training is associated with distinct remodeling signature, which can potentially be used for evaluating and predicting clinical outcomes
Pkhd1
Autosomal-recessive polycystic kidney disease (ARPKD; MIM #263200) is a severe, hereditary, hepato-renal fibrocystic disorder that causes early childhood morbidity and mortality. Mutations in the polycystic kidney and hepatic disease 1 (PKHD1) gene, which encodes the protein fibrocystin/polyductin complex (FPC), cause all typical forms of ARPKD. Several mouse lines carrying diverse, genetically engineered disruptions in the orthologous Pkhd1 gene have been generated, but none expresses the classic ARPKD renal phenotype. In the current study, we characterized a spontaneous mouse Pkhd1 mutation that is transmitted as a recessive trait and causes cysticliver (cyli), similar to the hepato-biliary disease in ARPKD, but which is exacerbated by age, sex, and parity. We mapped the mutation to Chromosome 1 and determined that an insertion/deletion mutation causes a frameshift within Pkhd1 exon 48, which is predicted to result in a premature termination codon (UGA). Pkhd
The Evolution of Word Composition in Metazoan Promoter Sequence
The field of molecular evolution provides many examples of the principle that molecular differences between species contain information about evolutionary history. One surprising case can be found in the frequency of short words in DNA: more closely related species have more similar word compositions. Interest in this has often focused on its utility in deducing phylogenetic relationships. However, it is also of interest because of the opportunity it provides for studying the evolution of genome function. Word-frequency differences between species change too slowly to be purely the result of random mutational drift. Rather, their slow pattern of change reflects the direct or indirect action of purifying selection and the presence of functional constraints. Many such constraints are likely to exist, and an important challenge is to distinguish them. Here we develop a method to do so by isolating the effects acting at different word sizes. We apply our method to 2-, 4-, and 8-base-pair (bp) words across several classes of noncoding sequence. Our major result is that similarities in 8-bp word frequencies scale with evolutionary time for regions immediately upstream of genes. This association is present although weaker in intronic sequence, but cannot be detected in intergenic sequence using our method. In contrast, 2-bp and 4-bp word frequencies scale with time in all classes of noncoding sequence. These results suggest that different genomic processes are involved at different word sizes. The pattern in 2-bp and 4-bp words may be due to evolutionary changes in processes such as DNA replication and repair, as has been suggested before. The pattern in 8-bp words may reflect evolutionary changes in gene-regulatory machinery, such as changes in the frequencies of transcription-factor binding sites, or in the affinity of transcription factors for particular sequences
ããã©ã®è¶³éšåœ¢æ掻æ§åãããããïœïœ-ïŒïŒïŒã®æ©èœè§£æ
ãè
è
žåç©ã®äžçš®ãæ·¡æ°Žç£ãã¯ãããã©ïŒHydra magnipapillataïŒã¯ãäºå±€ã®äžç®çµç¹ã现é·ãè¢ç¶ãšãªã£ãããã®äžç«¯ã«é ãä»ç«¯ã«è¶³ããããšããåçŽãªåœ¢æ
ãããŠããããã®äœå¶ã¯æŸå°çžç§°ã§é â足ïŒäžâäžïŒã®äžæ¬¡å
軞ã§ãããããã©ã¯ã匷ãæ£ç¢ºãªåçèœåãæã€ãäŸãã°ãé ãšè¶³ãåãé€ããŠããæ°æ¥ã§å
ã®é â足軞ã«åŸã£ãŠãå¿
ãé ããã£ãåŽããã¯é ãã足ããã£ãåŽããã¯è¶³ãåçããããã®çŸè±¡ã¯ãããã©ã®äœã«æ¥µæ§ãããããšã瀺ããŠããããŸãããã®åçäœã¯ããµã€ãºã¯å°ãããªã£ããã®ã®åœ¢æ
çãªéãã¯ãªãããã®ããã©ã«ããã極æ§ã«é¢ããŠãéå»ã«å€ãã®çµç¹ç§»æ€å®éšãè¡ããããããã®çµæãããããã©ã®äœã«ã¯é ãšè¶³ããããããäœè»žã«æ²¿ã£ãŠåŸé
ããªã圢æèœãšæå¶èœãšãããããããã®åŸé
ã«ãã£ãŠæ¥µæ§ãäœãããŠãããšããäœçœ®æ
å ±ã¢ãã«ãæå±ãããŠããããããããã®åŸé
ã極æ§ã®å®äœãšãªãå åãååæ©æ§ã«ã€ããŠã¯ãè¿å¹Žåè£ååã®åé¢ã解æãªã©ãé²ã¿å§ããŠã¯ããããæªã ã»ãšãã©åãã£ãŠããªããããã§æ¬ç 究ã§ã¯ãããã©ã«ããã極æ§ãšãã¿ãŒã³åœ¢æã®æ©æ§ãååã¬ãã«ã§è§£æããããšãç®çã«ãçŸåšæã
ã®ç 究宀ã§è¡ãããŠããããããæ§æ
å ±ååã®å€§èŠæš¡ã¹ã¯ãªãŒãã³ã°ã®éçšã§åé¢ãããããããã®äžããã圢æ
圢æã«åœ±é¿ãäžããååãéžã³åºãããã®æ©èœè§£æãè¡ãããšã«ãããå®éšã«çšããHym - 323ã¯ãã¢ããé
ž16æ®åºãããªãæ°èŠããããïŒKWVQGKPTGEVKQIKFïŒã§ããã®é
åã¯ããã©ã®åœ¢æ
圢æå åãšããŠåå®ãããç¥çµããããhead activatorãšCæ«åŽã®ã¢ããé
žé
åã50ïŒ
äžèŽããŠããããŸããã¹ã¯ãªãŒãã³ã°ã®éçšã§è¡ã£ãŠãã掻æ§æ€å®ãå³ã¡ãããããããã©ã®éºäŒåçºçŸã«åœ±é¿ãäžãããã©ãããDifferentialãdisplay - PCRæ³ã§æ€å®ããçµæã¯ãããžãã£ãã§ãã£ãããšãããHym - 323ã¯æ
å ±ååã§ãããšèããããåãã«ãHym - 323ã®ããããã®é
åäžã«å®å®åã«é¢äžããæ§ãªé
åãã修食ãããã¢ããé
žãèŠãããªãã£ãããšããã飌è²æ°Žäžã«ãããå®å®æ§ã«ã€ããŠèª¿ã¹ãããã®çµæãå®å®æ§ã¯æ¯èŒçäœããç¹ã«å
ã«åŒ±ãããšãåãã£ãã次ã«ãã®ç¹ãèæ
®ããŠHym - 323ã®æ©èœè§£æãè¡ã£ããHym - 323ã®Cæ«åŽããé éšåçä¿é²ã现èå¢æ®ãç¥çµååä¿é²æŽ»æ§ãæã€head activatorãšçžåæ§ãé«ãã£ãããšããããŸãé éšåçãšçŽ°èå¢æ®ãååãžã®åœ±é¿ã«ã€ããŠèª¿ã¹ãããã®çµæãé éšåçããäžç®çŽ°èãé现èã®å¢æ®ãç¥çµçŽ°èãåºçŽ°èã®ååãªã©ãžã®åœ±é¿ã¯æ€åºã§ããªãã£ãã次ã«ãHym - 323ã®è¶³éšåçãžã®äœçšãã2çš®é¡ã®è¶³éšç¹ç°çããŒã«ãŒã足éšç¹ç°çãã«ãªãã·ããŒãŒæŽ»æ§ãšãããã©ã®è¶³ç€çŽ°èããåæ³ãããç²æ§ç©è³ªãç¹ç°çã«èªèããã¢ãã¯ããŒãã«æäœAEO3ãšãçšããç°ãªã£ãæ¹æ³ã«ãã£ãŠèª¿ã¹ãããã®çµæãã©ã¡ãã®å®éšã«ãããŠãHym - 323åŠçã«ãããæªåŠçã®å¯Ÿç
§çŸ€ãšæ¯ã¹ãŠææãªè¶³éšåçä¿é²ãèŠãããããŸãããã«ãªãã·ããŒãŒæŽ»æ§ãçšããŠHym - 323ã®æ¿åºŠäŸåçãªäœçšã調ã¹ããšããã10-9Mãã10-6Mã®ç¯å²ã«ãããŠãæ¿åºŠäŸåçãªæŽ»æ§ã®äžæãèŠãããããããã©ã®åœ¢æ
圢æã«ã¯ãäžç®çµç¹ãäž»èŠãªåœ¹å²ãæ
ã£ãŠããããäžéšãé现èç³»èã®çŽ°èãé¢äžããŠããããšã瀺åãããŠãããããã§ãHym - 323ã®è¶³éšåçã®ä¿é²å¹æããçŽæ¥äžç®çŽ°èã«åããããçµæãªã®ãã©ããã«ã€ããŠèª¿ã¹ããããé现èç³»èã®çŽ°èãæããªãäžç®çµç¹ã®ã¿ãããªãããã©ïŒäžç®ããã©ïŒãçšããããã®çµæãäžç®ããã©ãçšããå Žåã§ããæ£åžžããã©ãçšããå Žåãšåçãªåçä¿é²æŽ»æ§ãã¿ãããããã£ãŠãHym - 323ã¯çŽæ¥äžç®ã«äœçšããŠãããšèãããããããé现èãä»ãã掻æ§ããããã©ããã«ã€ããŠã¯ããŸã åãã£ãŠããªãããHym - 323ã¯äžç®çµç¹ã«åããããŠè¶³éšåçãä¿é²ããŠããããšãããããã©ã®äœè»žã«æ²¿ã£ã足éšåœ¢æèœã®åŸé
ã«åœ±é¿ãåãŒããŠããå¯èœæ§ãèãããããããã§ãåŽæ¹ç§»æ€æ³ãçšããŠèª¿ã¹ãããšã«ãããHym - 323åŠçåäœããçµç¹çãåãåºããæªåŠçã®åäœã®åãäœçœ®ãžç§»æ€ããããã®çµæãããããåŠçããã移æ€çã¯ãæªåŠçã®çµç¹çã«æ¯ã¹ãŠãææã«ç°æçãªè¶³éšåœ¢æã®èªå°çãäžæããããåŸã£ãŠã足éšåœ¢æèœã®åŸé
ã¯ãHym - 323ã«ããé«ãããããã®ããåŽæ¹ç§»æ€å®éšã«ãããŠè¶³éšåœ¢æã®èªå°ãã¿ããããšèããããããããŸã§è¡ã£ãäžé£ã®çµç¹åŠçææ³ã«ããæ©èœè§£æã®çµæãããHym - 323ã¯çŽæ¥äžç®ã«äœçšãã现èã®æã€è¶³éšåœ¢æèœãåŒãäžãã足éšåœ¢æãåçã®ä¿é²ãèªå°ããããšã瀺åããããã现èå
ã«ãããHym - 323ã®ååžãã¿ãŒã³ããã®äœçšçµè·¯ã«ã€ããŠèª¿ã¹ãããã«ããŸãhym - 323éºäŒåã®åé¢ãè¡ã£ããçž®éãã©ã€ããŒã«ããPCRãšncested PCRãã©ã€ãã©ãªãŒã®ã¹ã¯ãªãŒãã³ã°ã«ãã£ãŠãHym - 323ããããåé§äœã¿ã³ãã¯è³ªãã³ãŒãããã»ãŒå
šé·ã®hym - 323 cDNAãåé¢ãããäºæ³ã¢ããé
žé
åäžã«ã¯ãCæ«åŽã®æ«ç«¯ã«Hym - 323ã1ã³ããŒã³ãŒããããŠããã ãã§ãé¡äŒŒã®é
åãä»ã®æ¢ç¥ã®ããããé
åãªã©ã¯ã¿ãããªãã£ãããŸãNæ«åŽã«ã·ã°ãã«é
åãããé åãã¿ãããªãã£ãã次ã«ãhym - 323 mRNAã®ç©ºéççºçŸããwhole mount in situ hybridizationæ³ãšããŒã¶ã³ãããã解æãçšããŠèª¿ã¹ãããã®çµæãäœã®äž¡ç«¯ã®æ§é ïŒè§Šæãå£äžã®å€èèçµç¹ãšè¶³ç€ïŒãé€ãå
šäœã§ããã€å
å€äºå±€ã®äžç®çµç¹ã§äžæ§ã«çºçŸããŠããããšãåãã£ãããã®ããšãããHym - 323ã¯äžç®çŽ°èã§åžžã«åæãããŠãããäžç®æ§ããããïŒepitheliopeptideïŒã§ããããšãåãã£ããã以äžã®ç 究ãããHym - 323ã¯äžç®çŽ°èã§åæãããçŽæ¥äžç®ã«åããã足éšåœ¢æã®èª¿ç¯ãè¡ã圢æ
圢æå åã§ããå¯èœæ§ã瀺åããã
Procese of the Enactment of Lost Article Act in 9th Year of the Meiji
äžãã¯ããã,äºãç¶æ°ä»¥åŸã«æŒããéºå€±ç©æ³ã®è®é·éçš,äžãææ²»åæã«æŒããæãåæ³åŸã®ææ³æŠè§,åãæ¹æ£ã®åæ©,äºãå
é£ã«æŒããä¿®æ£éçš,å
ãå
èé¢ã«æŒããä¿®æ£éçš,äžããã
- âŠ